Janani Rangaswami @RangaswJ Twitter profile

Last Seen Profiles

@Alex_Cerrato

@KhaleejMag

@esmeewsocial

@StoryTeller_Cos

@dmandisi

@danner

@LaloTenorio_

@lalshareef

@garry_keller

@KnoxUrbanLeague

@kasen_kinchen

@TheSabiRadio

@MaccaFrank

@zzrp0

@lincolixavier

@Ofeliaagl

@baoloc11092005

@NavarrodeArango

@bsnfpur

@BangAhmtfq

@KristiinaHeino1

@HIMMYTURNER69

@SlaysCryptic

@progage_co

@Nucleose

@norrawit_nt

@quieromusicatv

@flowhash31

@OpTic_SamShot

@TyCi_46

@Coach_SnyderGT

@yogflorida7v7

@kuzunue

@nana_partizan

@Prefecture50

@Drewd0g_

Janani Rangaswami

@RangaswJ

2 years

Delighted to share this review in @NEJMEvidence with @KevinBryanLo on Mechanistic Insights in # Cardiorenal Syndrome @KidneyInCVD @DrRajivsankar @mvaduganathan @AmirKazory @BhallaResearch @GW_Nephrology @GWtweets @KatherineTuttl8

15

143

448

Janani Rangaswami

@RangaswJ

6 months

Proud mom moment 😍 @RamaniBalu1 @RajgopalRadhika @ChiadiNdumele @BhallaResearch

Radhika Rajgopal Singh

@RajgopalRadhika

6 months

Our youngest (14 years old!) abstract presenter at #AHA23 . Such an impressive presentation and yes, a future AHA member for sure! ⁦ @RangaswJ ⁩

14

54

556

8

9

159

Janani Rangaswami

@RangaswJ

6 months

Attending #AHA2023 ? Don't miss these exciting #Cardio -Kidney sessions spanning critical care cardiology, clinical trial design, cardiorenal syndrome, #AHA scientific statement on home dialysis and cardiovascular effects, and much more !! ⁦⁦

1

18

63

Janani Rangaswami

@RangaswJ

3 years

Delighted to share our work on eligibility for #SGLT2i for #HF without the race coefficient for eGFR calculation. Important implications as we move towards race- neutral eGFR reporting as a community #cardiorenal @jaccjournals

4

17

61

Janani Rangaswami

@RangaswJ

1 year

Here is my dash of red for #GoRedForWomen 😊 @KidneyInCVD @staruschenko @DeniseLevyHear1 @RajgopalRadhika @lillie_noe

4

2

50

Janani Rangaswami

@RangaswJ

3 years

Honored to be part of this ⁦ #AHA21 symposium looking at #Implementation strategies for #SGLT2i with Prof.Eugene Braunwald and Dr.John Kevin Tucker ⁦ @KidneyInCVD ⁩ ⁦⁩ ⁦⁩ ⁦ @BhallaResearch ⁩ ⁦ @staruschenko ⁩ ⁦ @DrRajivsankar ⁩ ⁦ @DrKene ⁩

2

14

44

Janani Rangaswami

@RangaswJ

4 years

Delighted to work on this @AHAScience statement from the @KidneyInCVD with such a stellar writing team. Important step towards fostering #cardiorenal #CaReMe collaboration @Nephro_Sparks @BhallaResearch @asouth_neph @staruschenko @KatherineTuttl8

Muthu Vaduganathan

@mvaduganathan

4 years

🚨 Now Out in @CircAHA Cardiorenal Protection with #SGLT2i & #GLP1RA : Scientific Statement from 5 @American_Heart Councils chaired by @RangaswJ On the heels of #DAPACKD , 📄 highlights truly historic shifts in the care of 1 of our highest risk populations

7

59

157

3

12

41

Janani Rangaswami

@RangaswJ

7 months

Grateful and honored to co-chair this important work in the #Cardio -Kidney-Metabolic space with @ChiadiNdumele and #Sheryl Chow! New horizons in the #CKM syndrome across definition, staging, approach to screening, prevention and management😊

AHA Science

@AHAScience

7 months

Cardiovascular-Kidney-Metabolic Syndrome: a health disorder due to connections among obesity, diabetes, chronic kidney disease & CVD. 📖 @CircAHA ✍️ Chiadi E. Ndumele, MD, PhD, MHS & @RangaswJ More on defining, screening, and treating this syndrome:

4

66

131

2

21

43

Janani Rangaswami

@RangaswJ

2 years

Delighted to share this perspective piece: Changing the Trajectory of Heart Failure and Kidney Diseasealong with #Eugene Braunwald, ⁦⁦ @KatherineTuttl8 ⁩ ⁦ @gchertow ⁩ ⁦ @HeartBobH ⁩ ⁦ @BhallaResearch ⁩ ⁦ @staruschenko ⁩

2

12

40

Janani Rangaswami

@RangaswJ

1 year

Super proud of my #cardiorenal superstar mentee @KevinBryanLo for matching @BrighamWomen ’s cardiology fellowship. The #cardiorenal space is in great hands with such talent @mvaduganathan @EinsteinHealth @AHAScience @RajgopalRadhika

Brigham & Women's CV Fellows

@BrighamFellows

1 year

Welcome future colleagues! We are so excited to see what you accomplish. #Match2023 #CardioTwitter

21

25

420

5

4

41

Janani Rangaswami

@RangaswJ

4 years

Sharing our letter “AntiHTN drugs and risk of COVID-19? - ” in response to the original piece ⁦ @LancetRespirMed ⁩ . In the midst of panic, it’s important that opinion does not precede science ⁦ @BhallaResearch ⁩ ⁦⁦ @KidneyInCVD ⁩ ⁦

Antihypertensive drugs and risk of COVID-19?

Lei Fang and colleagues1 postulate that because severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to the angiotensin-converting enzyme 2 (ACE2) receptor to facilitate host cell...

www.thelancet.com

2

14

39

Janani Rangaswami

@RangaswJ

3 years

It was an absolute honor to moderate this distinguished Heart-Kidney panel discussion ! We had over 300 K impressions during the live telecast! The recording will be posted shortly. @AHAScience @BhallaResearch @KidneyInCVD @staruschenko @DrMarthaGulati

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

@DrMarthaGulati

3 years

The KCVD Council Heart/Kidney Panel is starting now! Hear from the giants Dr. Braunwald, @HeartBobH @gchertow et al. Hosted by @RangaswJ @AHAScience @American_Heart

1

7

29

3

6

37

Janani Rangaswami

@RangaswJ

4 years

Delighted to share link to this podcast with @mvaduganathan and @KatherineTuttl8 for @AHAScience and @AmDiabetesAssn #CaReMe 2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD - Know Diabetes by Heart

5

10

37

Janani Rangaswami

@RangaswJ

7 months

Accompanying ⁦ @AHAMeetings ⁩ Scientific Synopsis that describes the scientific underpinnings of the concepts outlined in the #CKMH #Presidential Advisory ⁦ @KidneyInCVD ⁩ ⁦ @ASNKidney ⁩ ⁦ @ChiadiNdumele ⁩ ⁦ @RajgopalRadhika ⁩

1

7

31

Janani Rangaswami

@RangaswJ

6 months

#AHA23 state of the art session on Dialysis and the Heart. Listen to world class experts in this space #Heart -Kidney symposium this afternoon! ⁦ @ChrisChanUHN ⁩ ⁦ @jordy_bc ⁩ ⁦ @KidneyInCVD ⁩ ⁦ @goKDIGO ⁩ ⁦ @RajgopalRadhika ⁩

2

4

31

Janani Rangaswami

@RangaswJ

3 years

Delighted to be part of the Heart/Kidney webinar from @KidneyInCVD @AHAScience with Prof.Eugene Braunwald, @HeartBobH @gchertow @BhallaResearch @staruschenko @KatherineTuttl8 ! What an amazing range of expertise in the #cardiorenal space.

Kidney in Cardiovascular Disease

@KidneyInCVD

3 years

We are very excited about our first Heart/Kidney Webinar! We have an amazing lineup of speakers in the panel so please consider registering! "KCVD Council Heart/Kidney Panel Thu, Oct 14, 2021 at 1:00 PM CDT | Eventbrite"

0

20

35

1

5

30

Janani Rangaswami

@RangaswJ

6 months

Super proud mentorship moment 😊 Star ⁦ @GWSMHS ⁩ IM resident and current ⁦ @UCLAHealth ⁩ cardiology fellow, @ShayV_MD presenting at #AHA 23 today on a single center RCT she led as a PGY 3 resident !! #CKMH #Multidisciplinary care 1/n

6

1

31

Janani Rangaswami

@RangaswJ

4 years

Glad to share this new textbook on Kidney Disease in the Cardiac Catheterization Laboratory . Another step towards a seamless cardiorenal collaborative care model # Cardiorenal# Multidisciplinary #heart -kidney

Kidney Disease in the Cardiac Catheterization Laboratory

link.springer.com

3

6

28

Janani Rangaswami

@RangaswJ

6 months

The amazing ⁦ @SusanQuaggin ⁩ will be giving the keynote talk soon for ⁦ @KidneyInCVD ⁩ ⁦ @ASNKidney ⁩ Young Investigator Symposium!! From Potassium and Podocytes to Policy #cardiorenal #physician -scientist ⁦

1

6

25

Janani Rangaswami

@RangaswJ

4 months

Gratifying to see the sex specific , race free AHA total CVD risk prediction tool, #PREVENT live now ! Even more gratifying to see #kidney function as part of the risk calculator 😊 @KidneyInCVD @RajgopalRadhika @SusanQuaggin @KatherineTuttl8 @mvaduganathan @ASNKidney

Radhika Rajgopal Singh

@RajgopalRadhika

4 months

👇👇👇….. and here we go with the NEW total CVD risk prediction tool. Watch this space for the add-on functions to go live soon! @HeartDocSadiya @JoeCoresh @ChiadiNdumele @RangaswJ @dmljmd @MariellJessup

0

5

21

0

7

26

Janani Rangaswami

@RangaswJ

6 months

Congrats @KatherineTuttl8 ! It's a huge privilege to work with you in the #CKM space😊 @KidneyInCVD @AHAScience @ChiadiNdumele @RajgopalRadhika @lillie_noe @BhallaResearch @mvaduganathan @NicholasSusanne @SusanQuaggin

Matthew Sparks, MD

@Nephro_Sparks

6 months

Congrats @KatherineTuttl8 on receiving the John Peters award #kidneywk #flozinate

0

2

30

3

4

26

Janani Rangaswami

@RangaswJ

6 months

Standing room only for the GDMT/decongestion in HF and CKD session ! #AHA23 ⁦ @KidneyInCVD ⁩ ⁦ @AHAMeetings ⁩ ⁦ @RajgopalRadhika ⁩ ⁦ @BhallaResearch ⁩

0

4

25

Janani Rangaswami

@RangaswJ

3 years

Another important and timely discussion on the evolving paradigm of aldosteronism, BP and # cardiorenal disease# AHA21 ⁦ @BhallaResearch ⁩ ⁦ @staruschenko ⁩ ⁦ @KidneyInCVD ⁩ ⁦ @CouncilonHTN ⁩ ⁦ @DaichiShimbo ⁩ ⁦ @AHAMeetings ⁩ ⁦ @AnastasiaSMihai ⁩

0

8

24

Janani Rangaswami

@RangaswJ

3 years

Please join #AHA21 for cutting edge symposia jointly curated by ⁦ @KidneyInCVD ⁩ & ⁦ @CouncilonHTN ⁩ of ⁦ #AHA ! ⁦ @BhallaResearch ⁩ ⁦ @staruschenko ⁩ ⁦⁦⁩ ⁦ @Carmendemigue12 ⁩ ⁦ @NishaKidneyDoc ⁩ ⁦ @annetkiraboc1 ⁩ ⁦ @JohnRMontford ⁩

1

12

24

Janani Rangaswami

@RangaswJ

3 years

Delighted to collaborate on @AHAScience statement by @KidneyInCVD on #AS in #CKD , led by @PPibarot and Gautam Shroff with @BhallaResearch @staruschenko @NicoleBhaveMD @SripalBangalore @taraichang @VinodThourani

Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From...

Aortic stenosis with concomitant chronic kidney disease (CKD) represents a clinical challenge. Aortic stenosis is more prevalent and progresses more rapidly and unpredictably in CKD, and the presence

www.ahajournals.org

3

11

24

Janani Rangaswami

@RangaswJ

2 years

Outstanding Keynote address by Prof.Susanne Nicholas for the #Early Career symposium of the ⁦ @KidneyInCVD ⁩ !! ⁦ @AHAScience ⁩ ⁦ @ASNKidney ⁩ ⁦ @staruschenko ⁩ ⁦ @BhallaResearch ⁩

2

5

24

Janani Rangaswami

@RangaswJ

8 months

Look forward to this great event jointly hosted by @KidneyInCVD @AHAMeetings and @ASNKidney ! Can’t wait to hear @SusanQuaggin deliver the keynote and hear our @AHAScience funded researchers share their great work ! @RajgopalRadhika @staruschenko

Kidney in Cardiovascular Disease

@KidneyInCVD

8 months

. @KidneyInCVD members! Are you attending #KidneyWk in November?? Please come and 🍾🍾 our 2023 Young Investigator winner @benofreedman and @AHAScience funded researchers @SianPiret and @hannahmcostello . @ASNKidney past president @SusanQuaggin will be the keynote speaker!!

0

8

23

1

4

24

Janani Rangaswami

@RangaswJ

2 years

Important new ⁦ @AHAScience ⁦ @KidneyInCVD #statement ⁩ Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association ⁦ @KristaLentine ⁩

Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candida...

Coronary heart disease is an important source of mortality and morbidity among kidney transplantation and liver transplantation candidates and recipients and is driven by traditional and nontradition

www.ahajournals.org

1

12

25

Janani Rangaswami

@RangaswJ

3 years

Happy to share this perspective piece in @CircOutcomes with @mvaduganathan & @KatherineTuttl8 on barriers to #implementation of Cardio-Renal-Metabolic Care Models @AgarwalRajivMD @BhallaResearch @KidneyInCVD @gchertow @SusanQuaggin

Cardio-Renal-Metabolic Care Models

www.ahajournals.org

1

8

23

Janani Rangaswami

@RangaswJ

3 years

Do not miss this #AHA21 symposium on navigating a COVIDilized scientific world as an early career investigator! Amazing speaker line up😊⁦ @NishaKidneyDoc ⁩ ⁦ @jordy_bc ⁩ ⁦ @KidneyInCVD ⁩ ⁦ @CouncilonHTN ⁩ ⁦ @RajgopalRadhika ⁩ ⁦ @Carmendemigue12 ⁩ ⁦

1

6

23

Janani Rangaswami

@RangaswJ

6 months

The amazing ⁦ @jordy_bc ⁩ discussing blood pressure targets in patients on dialysis, featuring content from the recent #AHA ⁦ @KidneyInCVD ⁩ statement on this topic !

0

6

22

Janani Rangaswami

@RangaswJ

2 years

#ADA2022 Deighted to speak with @BakrisGeorge @P_Rossing and #Daniel van Raalte on breakthrough therapies for #DKD #NOLA @goKDIGO @KidneyInCVD @KatherineTuttl8 #SGLT2i #finerenone

0

4

21

Janani Rangaswami

@RangaswJ

4 years

Landmark day at #AHA19 to hear about data from #ISCHEMIA and #ISCHEMIA -CKD ! The cardiorenal community has been waiting for this a long time. Congratulations in advance @SripalBangalore ! @Social_CRSA @ASNKidney @AHAMeetings @KidneyInCVD

4

3

21

Janani Rangaswami

@RangaswJ

6 months

Delighted to connect with star mentee @ShayV_MD at #AHA23 ⁦ @GWSMHS ⁩, cardiology fellow ⁦ @UCLA ⁩! She will present on the feasibility and design of a pilot trial she led on a #cardio -kidney coordinated model at GW as a resident #Akman award

0

2

20

Janani Rangaswami

@RangaswJ

3 years

In the backdrop of "renalism" with limited representation of patients with #CKD in trials, the elegantly done #CLICK trial is a big win. What a pioneering contribution by @AgarwalRajivMD ! @BhallaResearch @KidneyInCVD @staruschenko #KidneyWk

1

7

21

Janani Rangaswami

@RangaswJ

2 years

Delighted to speak at @HofstraKidney today on cardiorenal syndrome ! Very engaging discussion,and great to catch up with old friends from our Cornell fellowship days @kdjhaveri @renalmyeloma 😊

HofNorthwell Kidney

@HofstraKidney

2 years

Amazing slide decks @RangaswJ

0

1

6

1

3

21

Janani Rangaswami

@RangaswJ

4 years

Ushers in a new era for cardiorenal medicine! Starting from the fact that a major CKD trial is presenting at a major cardiology meeting 💪🏻💪🏻 @KidneyInCVD @BhallaResearch @mvaduganathan @Social_CRSA #CaReMe

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

@DrMarthaGulati

4 years

#ESCCongress is a meeting for Cardiologists and Nephrologists! DAPA- CKD presented and enrolled patients with CKD with or without DM: randomized to Dapagliflozin vs Placebo ♥️Dapa is a diuretic and does much more ♥️Renal Benefit seen in those CKD treated with Dapa vs placebo

7

36

103

0

5

21

Janani Rangaswami

@RangaswJ

4 years

Game changing trial in the world of cardiorenal medicine! 🙏🙏to @HeerspinkHiddo and the DAPA-CKD team for bringing this to fruition @BhallaResearch @KidneyInCVD @AHAMeetings @RajgopalRadhika

Todd Neale

@ToddNeale

4 years

"The DAPA-CKD trial has shown dapagliflozin’s potential as a long-awaited new treatment option for patients with chronic kidney disease." @HeerspinkHiddo @RangaswJ @Grobbee #ESCCongress @TCTMD

0

1

2

0

2

20

Janani Rangaswami

@RangaswJ

2 years

Outstanding panelists and moderators for this upcoming @KidneyInCVD event as part of the Heart-Kidney webinar series! Do register and join this discussion! @SripalBangalore @NishaKidneyDoc @ErinMichos @KristaLentine @rallamee @BhallaResearch @staruschenko

Kidney in Cardiovascular Disease

@KidneyInCVD

2 years

Mark your calendars! The next . @KidneyInCVD Heart/Kidney series webinar will be on Jan 26 and will focus on Coronary Artery Disease in Patients with Kidney Disease. Register at:

1

13

30

0

8

20

Janani Rangaswami

@RangaswJ

4 years

Important guidance with the ongoing confusion of using RAASI with the current COVID-19 pandemic . If anything , abrupt cessation esp in those with heart failure would be concerning given potential for superadded myocarditis with CoNV

John P Erwin III MD MBA FACC

@HeartOTXHeartMD

4 years

#ESH Statement on #COVID19 | European Society of Hypertension HT @KhandelwalMD

2

13

28

1

7

20

Janani Rangaswami

@RangaswJ

6 months

Starting at 2 pm today! #AHA23 Heart-Kidney symposium ! Join experts in cardiology and nephrology in Room 126B #HF #GDMT #Renalism ⁦ @KidneyInCVD ⁩ ⁦ @AHAMeetings ⁩ ⁦ @goKDIGO ⁩ ⁦ @BiykemB ⁩ ⁦ @MariellJessup ⁩ ⁦⁦ @RajgopalRadhika ⁩

1

4

21

Janani Rangaswami

@RangaswJ

6 months

And it will be the biggest honor of my life to feature in a cartoon with ⁦ @gchertow ⁩ as part of his outstanding summary of the AHA # CKM Presidential Advisory 🙏😊⁦⁩ ⁦⁦ @ChiadiNdumele ⁩ ⁦ @RajgopalRadhika ⁩ ⁦ @KidneyInCVD ⁩ ⁦

1

2

18

Janani Rangaswami

@RangaswJ

4 years

Impressive presentation by Prof. Agarwal on the remarkable results from # FIDELIO-DKD. Landmark addition to #CKD therapeutic armamentarium ⁦ @BhallaResearch ⁩ ⁦ @mvaduganathan ⁩ ⁦ @KatherineTuttl8 ⁩ ⁦ @ASNKidney ⁩ #kidneyweek

0

5

19

Janani Rangaswami

@RangaswJ

2 years

Not to be missed ! Join us at #AHA22 for high impact #Heart -Kidney content at the pre-Sessions track on Nov 4 @KidneyInCVD @BhallaResearch @staruschenko @KatherineTuttl8 @lillie_noe @RajgopalRadhika @NishaKidneyDoc

AHA Science

@AHAScience

2 years

At #AHA22 there will be an optional day prior to the Nov 5 opening sessions. There will be something for everyone! 41 sessions, 9 hours with various tracks including: ➡️ Kidney Symposia ➡️ Pediatric Cardiology ➡️ Early Career Sessions ➡️ Frontiers in Science 🎥 @dramitkhera

1

7

30

2

5

19

Janani Rangaswami

@RangaswJ

7 months

Thanks @staruschenko ! This was a great multi specialty collaboration with @ChiadiNdumele and several other experts 😊 @AHAScience @RajgopalRadhika @KidneyInCVD

Alexander Staruschenko

@staruschenko

7 months

Great concept of the Cardiovascular-Kidney-Metabolic (CKM) Syndrome. @MitchElkind @RangaswJ @KidneyInCVD @AHAScience @CircAHA Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association | Circulation

0

7

34

0

2

18

Janani Rangaswami

@RangaswJ

2 years

Looking forward to this exciting #Heart -Kidney #LBCT at #AHA22 with co-moderator @dramitkhera , #SoMe moderator @kershawpatel and several eminent trialists and discussants! @PamTaubMD @manesh_patelMD @Oxford_NDPH @KidneyInCVD @AHAMeetings @RajgopalRadhika

Erin D. Michos, M.D.

@ErinMichos

2 years

I absolutely can't wait for this #LBCT session at #AHA22 @ahascience . Been waiting to see these trials report out: #EMPAKIDNEY #RESPECTEPA #OCEANaDOSE #SPORT . Late-Breaking Science: Changing How We Prevent Cardiovascular and Renal Disease. Sun Nov 6 5-6 pm Central in Main Event 1

1

15

64

0

4

18

Janani Rangaswami

@RangaswJ

2 years

Many thanks @DrRajivsankar for collaborating, @KevinBryanLo for leading this & all coauthors . Important to include patients with #CKD in #CV trials #renalism @KidneyInCVD @GW_Nephrology @mvaduganathan @JohnRMontford @ASNKidney

Dr.Rajiv Sankaranarayanan

@DrRajivsankar

2 years

1/5 🧵 Nice Trans-Atlantic #cardiorenal collaboration with Prof @RangaswJ ‘s team by @LivHospitals & @LiverpoolCCS 💥Need for wider inclusion of patients with advanced CKD in RCTs in HFrEF 💥 Dialysis & kidney transplant recipients underrepresented in HFrEF #heartfailure trials

1

8

29

0

2

17

Janani Rangaswami

@RangaswJ

2 years

Join us @KidneyInCVD for this upcoming Heart-Kidney webinar! @BhallaResearch @staruschenko @AHAScience

Kidney in Cardiovascular Disease

@KidneyInCVD

2 years

In 2 days!! Join us in our next . @KidneyInCVD #heartkidney webinar THIS WEDNESDAY Jan 26. Our panelists will be talking about #CAD in #CKD patients. Hurry and register at 👇🏽👇🏽

2

10

22

0

5

17

Janani Rangaswami

@RangaswJ

4 years

The cardiorenal community is grateful to #ISCHEMIA -CKD for a dedicated RCT on stable IHD in advanced CKD. No significant differences in primary/ secondary outcomes between INV and CON arms . Valuable information in this pt group. @SripalBangalore #AHA19

0

5

17

Janani Rangaswami

@RangaswJ

6 months

⁦ @KatherineTuttl8 ⁩ delivering a masterful talk on #GDMT in #CKD highlighting pivotal role of #CKD in determining CVD risk #Cardiovascular -Kidney-Metabolic ( CKM) syndrome ⁦ @RajgopalRadhika ⁩ ⁦ @ChiadiNdumele ⁩ ⁦ @KidneyInCVD ⁩ ⁦ @ASNKidney ⁩ ⁦

1

7

17

Janani Rangaswami

@RangaswJ

3 years

🙏🙏to @KristaLentine for leading this important work on adverse outcomes associated with post KTx P-HTN. Important to delve deeper into #cardiorenal interactions in KTx recipients, thanks for the collaboration ! @D_M_Dadhania @KidneyInCVD

Krista Lentine, MD,PhD | FASN | FAST

@KristaLentine

3 years

🙏🏾 @TransplantJrnl for publishing our @AST_KPCOP article ‘Incidence, Clinical Correlates & Outcomes of #PulmonaryHypertension after #KidneyTransplant ’.Post-KTx P-HTN is diagnosed in 1-in-10➕is associated w/ adverse outcomes.📊Research is needed to improve outcomes of P-HTN in KTx

1

9

26

1

7

17

Janani Rangaswami

@RangaswJ

6 months

Great to have you as part of the @KidneyInCVD symposium #GDMT #HF #CKD @AHAMeetings #AHA23

Iris Beldhuis

@iebeldhuis

6 months

Thanks again #AHA23 for the invitation to speak at the CardioKidney symposium on HF GDMT in CKD! 🫀💊 Honoured to be part of this amazing team @BrighamFellows again, thanks to the ongoing support from @CardiologyUmcg @AHAMeetings

1

3

24

0

3

17

Janani Rangaswami

@RangaswJ

6 months

The one and only ⁦ @gchertow ⁩ presenting and sharing his expertise and perspective on the ⁦ @AHAScience ⁩ #CKM Presidential Advisory!! ⁦ @ASNKidney ⁩ ⁦ @AHAScience ⁩ ⁦ @AHAMeetings ⁩ ⁦ @RajgopalRadhika ⁩ ⁦ @ChiadiNdumele ⁩ ⁦ @KatherineTuttl8 ⁩

1

16

Janani Rangaswami

@RangaswJ

1 year

Super grateful for the incredible work in the #heart -kidney space that @KidneyInCVD is spearheading! Here’s to more exciting work in 2023!! @BhallaResearch @staruschenko @RajgopalRadhika @NishaKidneyDoc @KatherineTuttl8 @mvaduganathan @lillie_noe @

Kidney in Cardiovascular Disease

@KidneyInCVD

1 year

. @KidneyInCVD wishes you the happiest of holidays and best wishes for 2023! Wishing you all happiness, peace and health in the new year. Happy holiday season! @RangaswJ @staruschenko @BhallaResearch @asouth_neph @niruramkumar

0

4

8

0

4

16

Janani Rangaswami

@RangaswJ

3 years

Thanks @Nephro_Sparks and @GarovicVesna for your impeccable leadership with this #AHA council wide effort! @KidneyInCVD @staruschenko @BhallaResearch @RajgopalRadhika

Matthew Sparks, MD

@Nephro_Sparks

3 years

SARS-CoV-2, COVID-19, and the Renin-Angiotensin System Pressing Needs and Best Research Practices Important statement from @AHA_Research council wide effort in @HyperAHA @BhallaResearch @Dan_Batlle @GarovicVesna @asouth_neph @RangaswJ and many others

2

9

43

0

3

16

Janani Rangaswami

@RangaswJ

6 months

Such an important part of the #AHA #CKM health initiative! Hear more about the new PREVENT equation for CVD events at the #CKM Main Event on Sunday! Huge thanks to @HeartDocSadiya @JoeCoresh @dmljmd for your leadership 🙏 @ChiadiNdumele

AHA Science

@AHAScience

6 months

🆕 This statement summarizes the background, rationale, and clinical implications for newly developed sex-specific, race-free risk equations: American Heart Association Predicting Risk of CVD EVENTs (PREVENT) ✍🏽 @HeartDocSadiya @JoeCoresh @dmljmd 🔗

2

72

166

1

6

16

Janani Rangaswami

@RangaswJ

2 years

Very successful second consensus conference of the Philadelphia Agreement on Gender Equity for #IM trainees #PAGE held today! Many thanks to co-leaders @LeiLeeMD @taminatorMD & #Alexandra Lane, and #SE @PAChapterACP @LWardMD @DarilynMoyer for the support!

2

4

16

Janani Rangaswami

@RangaswJ

7 months

Culmination of over a year’s work! Thanks for being such an amazing leader and co-chair @ChiadiNdumele ! You have truly earned your honorary fellowship in Nephrology at this point 🤣 @RajgopalRadhika @KatherineTuttl8 @SusanQuaggin @AHAScience

Chiadi Ndumele

@ChiadiNdumele

7 months

Excited to share an AHA Presidential Advisory and Scientific Statement on Cardiovascular-Kidney-Metabolic (CKM) Health, prepared by a multi-disciplinary group of clinicians and scientists and published in Circulation today.

4

26

90

1

2

16

Janani Rangaswami

@RangaswJ

6 months

⁦ @brendonneuen ⁩ presenting on lifetime benefits with combination of therapies in patients with T2D and albuminuria vs conventional care #SGLT2i #GLP -1RAs #finerenone #CKM ⁦ @KidneyInCVD ⁩ ⁦ @AHAScience ⁩ ⁦ @AHAMeetings ⁩

0

2

15

Janani Rangaswami

@RangaswJ

11 months

Huge congrats @SusanQuaggin from your @KidneyInCVD colleagues on being named Chair of Medicine @NUFeinbergMed ! As a prior #Seldin lectureship awardee and AHA Distinguished Scientist (2022) via @KidneyInCVD we can’t wait to see the new heights you scale😊

Northwestern Feinberg School of Medicine

@NUFeinbergMed

11 months

We are excited to announce that @SusanQuaggin , MD, has been named the new chair of the Department of Medicine. She will be the first woman to serve as @NorthwesternU 's chair of Medicine.

81

66

583

1

3

15

Janani Rangaswami

@RangaswJ

3 years

Elegant perspective on terminology impact in hypertension and high-normal BP labels by @AnastasiaSMihai

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

@DrMarthaGulati

3 years

Wonderful editorial by @AnastasiaSMihai in @CircOutcomes Words Matter: Hypertension and High Normal Blood Pressure Labels 💥 when labeled with a medical condition: can influence tx & adherence 💥affects attitude & understanding So words do matter!

14

49

137

1

6

15

Janani Rangaswami

@RangaswJ

4 years

Happy to share the collective work of the #CV workgroup of the @AST Kidney/ Pancreas COP on practice patternw for #CAD screening in asymptomatic # kidneytransplant candidates @KidneyInCVD @KristaLentine @StanfordNeph @CornellKidney @EinsteinHealth

Kidney Medicine

@KidneyMed

4 years

Coronary Artery Disease Screening of Asymptomatic #KidneyTransplant Candidates: Web-Based Survey of Practice Patterns in the US #OpenAccess @CunningBeans @ekamoltan @SweeLevea @D_M_Dadhania @RangaswJ @StanfordNeph @UMichKidney @UCIkidney @UTSWNephrology

0

7

14

1

4

15

Janani Rangaswami

@RangaswJ

2 years

@brendonneuen @hvanspall @FaiezZANNAD @kaulcsmc @mvaduganathan @georgeinstitute Look forward to this important session as part of the Heart-Kidney symposium at #AHA22 via @KidneyInCVD @staruschenko @BhallaResearch @lillie_noe @RajgopalRadhika @Carmendemigue12 @niruramkumar

0

8

13

Janani Rangaswami

@RangaswJ

3 years

It was a pleasure to “visit” @NU_Nephrology today and talk about cardiorenal syndrome and implementation of newer care models . Thanks for the invite @SusanQuaggin and your leadership in the field in these exciting times @ASNKidney

Susan Quaggin

@SusanQuaggin

3 years

.⁦ @RangaswJ ⁩ quoting ⁦ @KatherineTuttl8 ⁩ ... #sglt2i ’s is the gift that keeps giving -powerful kidney and heart protective effects!

0

3

14

0

3

14

Janani Rangaswami

@RangaswJ

2 years

Outstanding new @KidneyInCVD statement led by Prof. @ChrisChanUHN and Prof.Mark Sarnak on #CV effects of Home Dialysis! @TuftsMCKidney @WilsonTangMD @gchertow @KidneyPatients @AHAScience @CouncilonHTN @BhallaResearch @lillie_noe @RajgopalRadhika

Alexander Staruschenko

@staruschenko

2 years

Cardiovascular Effects of Home Dialysis Therapies: A new statement from @KidneyInCVD @AHA_Research @CircAHA

0

5

18

0

5

14

Janani Rangaswami

@RangaswJ

10 months

Look forward to an amazing program at @AHAMeetings in Philly soon! Thanks for your great leadership, @dramitkhera and @JoChikweMD ! @KidneyInCVD @RajgopalRadhika

Amit Khera

@dramitkhera

10 months

If you are looking for the very best in CV science come to #AHA23 !Backstage view of abstract slotting in action. Amazing breath of domains brought to life in compelling and engaging sessions by these amazing volunteers @AHAScience @AHAMeetings @JoChikweMD

1

12

57

1

2

14

Janani Rangaswami

@RangaswJ

6 months

#AHA23 Heart-Kidney symposium this afternoon ! Calling all critical care cardiologists, #HF cardiologists, nephrologists and #FIT ⁦ @KidneyInCVD ⁩ ⁦ @AHAMeetings ⁩ ⁦ @luck_urine ⁩ ⁦ @Carlos_DavilaMD ⁩ ⁦ @BhallaResearch ⁩ ⁦

0

2

13

Janani Rangaswami

@RangaswJ

2 years

Happening now at #AHA22 . Multidisciplinary flipped classroom style discussion on societal guideline in #CaReMe and #CaReMe multidisciplinary care models @mvaduganathan @MkosiborodMD @kershawpatel @AHAScience @KidneyInCVD

1

5

13

Janani Rangaswami

@RangaswJ

2 years

Honored to have Prof.Braunwald in this session sharing his thoughts on the #SGLT2i from a cardiologist’s perspective for the @KidneyInCVD & @CouncilonHTN organized symposia at #AHA21 @AHAScience @AHAMeetings @Carmendemigue12 @niruramkumar @RajgopalRadhika

John Montford

@JohnRMontford

2 years

#AHA21 day 2 #Flozin time baby! Starting with this session on implementation, the 🐘 in the room for all of us.

1

9

0

2

12

Janani Rangaswami

@RangaswJ

4 years

Dapagliflozin earns breakthrough therapy designation for CKD with, without type 2 diabetes ⁦ @KidneyInCVD ⁩ ⁦ @BhallaResearch ⁩ ⁦ @KatherineTuttl8 ⁩ ⁦ @mvaduganathan ⁩ ⁦ @staruschenko ⁩

1

2

13

Janani Rangaswami

@RangaswJ

2 years

Many congrats on this important work, @KatherineTuttl8 @JoshuaNeumiller and team! @KidneyInCVD @BhallaResearch @knightra @itsglendar @KidneyPatients @mvaduganathan

Katherine Tuttle

@KatherineTuttl8

2 years

Spokane doctor leads study finding high rates of chronic kidney disease with diabetes, disparities

0

5

52

0

3

13

Janani Rangaswami

@RangaswJ

7 months

Major emphasis on the role of #CKD as part of #CKM syndrome represented in the staging and approach to management. #cardio -kidney 🫘. Goal is to identify and treat excess adverse #CV risk across #CKD severity 💪🏻💪🏻

2

5

13

Janani Rangaswami

@RangaswJ

2 years

Join us in room S101B soon for this multidisciplinary session on shared decision making in patients with #advanced HF and #kidney disease #Heart -Kidney with experts from HF cardiology , nephrology, and palliative care med @KidneyInCVD @mrchrtfaildoc

0

4

13

Janani Rangaswami

@RangaswJ

4 years

Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease - Professional Heart Daily | American Heart Association

Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic...

professional.heart.org

0

4

13

Janani Rangaswami

@RangaswJ

2 years

Look forward to meeting several colleagues at this important @KidneyInCVD session @ASNKidney Kidney Week 2022! @BhallaResearch @AHAScience @lillie_noe @RajgopalRadhika

Alexander Staruschenko

@staruschenko

2 years

Mark your calendar if you plan to attend the ASN meeting. 12th KCVD Early Career Symposium! November 2, 7-8.30 PM (Hyatt Regency Orlando; 9801 International Dr., Ballroom LM). @KidneyInCVD @CouncilonHTN @AHA_Research @ASNKidney @NicholasSusanne @AnneMRamsey2

0

9

28

0

4

13

Janani Rangaswami

@RangaswJ

6 months

Welcoming the Queen of CRRT, Prof.Ashita Tolwani ⁦ @luck_urine ⁩ to #AHA23 for the Critical Care Cardiology #Heart -Kidney session today ? ⁦ @KidneyInCVD ⁩ ⁦ @AHAMeetings ⁩

2

13

Janani Rangaswami

@RangaswJ

4 years

Really important data shedding light on future advocacy work needed in the #CaReMe space to match the highest risk patients with appropriate disease modifying Rx #cardiorenal @KidneyInCVD @KatherineTuttl8 @AHAScience @RajgopalRadhika @BhallaResearch

Muthu Vaduganathan

@mvaduganathan

4 years

Medicaid Expansion & Antihyperglycemic Therapies in @ADA_Journals by @adsumarsono , @sara_rm84 , & colleagues. Low-income adults carry a disproportionate burden of CV disease. Improving insurance coverage represents a key determinant of therapeutic access.

0

18

53

0

3

13

Janani Rangaswami

@RangaswJ

6 months

⁦ @BigeOzkanMD ⁩ presenting on proteomic predictors of transitions in metabolic status in middle age ! #CKM #futurecardiologist #WIC ⁦ @RajgopalRadhika ⁩ ⁦ @ChiadiNdumele ⁩ ⁦ @JoeCoresh ⁩ #AHA23

0

3

12

Janani Rangaswami

@RangaswJ

2 years

Delighted to meet the Lahey Cardiology and Nephrology divisions as well as other institutional #cardiorenal collaborators! Gratifying to see huge trainee interest in this space. Look forward to more collaborations!

Saurabh S Dani, MD, MSc

@SaurabhSDani

2 years

Superb Grand Rounds @LaheyCardiology by the #TourDeForce of the #Cardiorenal world @RangaswJ ! Avoid Renalism, Decongestion with GDMT works, #learning and #delearning crucial, need a better renal biomarker, collaboration - Cardio-renal clinics, longitudinal f/u are needed!

2

7

24

0

2

12

Janani Rangaswami

@RangaswJ

6 months

Ashita Tolwani teaching CRRT for cardiologists and cardiac intensivist at the # Heart-Kidney symposium #AHA23 ⁦ @luck_urine ⁩ ⁦ @KidneyInCVD ⁩ ⁦ @BhallaResearch ⁩ ⁦ @Carlos_DavilaMD ⁩ ⁦ @jordy_bc ⁩

1

4

12

Janani Rangaswami

@RangaswJ

4 years

Editorial with @staruschenko and @BhallaResearch on changing landscape of #CKD therapies in @AJPRenal . Grateful to @KidneyInCVD @AHAScience for ongoing commitment to improving #cardiorenal outcomes

SGLT2 inhibitors: diabetic kidney disease and beyond | American Journal of Physiology-Renal...

journals.physiology.org

0

2

12

Janani Rangaswami

@RangaswJ

2 years

⁦ @brendonneuen ⁩ giving an excellent talk on interpretation of eGFR slope and nuances of using this as a #CardioKidney end point. Ssssion moderated by ⁦ @mvaduganathan ⁩ ⁦ @KidneyInCVD ⁩ ⁦ @AHAMeetings ⁩

0

4

12

Janani Rangaswami

@RangaswJ

6 months

Nice to see our group's work on invasive hemodynamics in #HRS featured in this session. Lead by superstar resident # Jerald Pelayo @JeffHealthEH and @BrighamWomens cardiology fellow @KevinBryanLo ! @AmirKazory #CRS physiology @KidneyInCVD

James Novak, MD PhD FACP FASN FNKF

@JamesNovakNeph

6 months

Hepatocardiorenal syndrome: diuresis in those with HRS and high PCWP may be better than volume expansion:

0

6

23

1

3

12

Janani Rangaswami

@RangaswJ

4 years

And the excitement builds :) @SripalBangalore getting ready to present #ISCHEMIA -CKD results soon ! Proud to collaborate with such fantastic minds 😊

0

12

Janani Rangaswami

@RangaswJ

6 months

Wonderful support for the @AHAScience #CKM Presidential Advisory 😊😊 🙏🙏 @SusanQuaggin for all your support for this work and #CKM health @RajgopalRadhika @ChiadiNdumele @KatherineTuttl8

Susan Quaggin

@SusanQuaggin

6 months

This Thanksgiving I am #grateful for the new CKM guidance from ⁦ @AHAScience - much needed team approach to advance equitable healthcare for patients!! ❤️ 🫘 endo ⁦ @DGlaucomflecken ⁩

3

14

101

0

1

12

Janani Rangaswami

@RangaswJ

2 years

Fantastic collaboration in the # cardiometabolic space # TRANSLATEHF! @AHAScience @AHAMeetings @KidneyInCVD

Muthu Vaduganathan

@mvaduganathan

2 years

Thankful to @AHAScience @DCRINews @AstraZeneca for ongoing support of #TRANSLATEHF The program is set to be continue for another yr, so stay tuned for more science around cardiometabolic Rx Grateful to @JCardFail @dranulala @met_hurt for expeditious review & #SimPub opportunity

1

14

46

1

3

12

Janani Rangaswami

@RangaswJ

5 months

Many thanks for the nuanced commentary ! @AshuNephro @SophieClaudel @ChiadiNdumele @RajgopalRadhika @MitchElkind @MariellJessup @KidneyInCVD

Ashish Verma

@AshuNephro

5 months

Cardiovascular-kidney-metabolic syndrome: A step toward multidisciplinary and inclusive care. Our commentary in ⁦ @Cell_Metabolism ⁩ led by ⁦ @SophieClaudel ⁩ ⁦ @RangaswJ ⁩ ⁦ @KatherineTuttl8 ⁩ ⁦ @bu_bmc_renal ⁩ ⁦ @American_Heart ⁩

4

8

26

0

1

11

Janani Rangaswami

@RangaswJ

2 years

@KidneyInCVD @staruschenko @BhallaResearch

Susan Quaggin

@SusanQuaggin

2 years

Urine tells all - the value of urine lytes and CV risk #KidneyRules ⁦ #AHA21

4

50

265

1

5

11

Janani Rangaswami

@RangaswJ

4 years

@mvaduganathan @AstraZeneca @brendonneuen @Cardiobro @ValleAlfonso @paomorejon @AshuNephro @ankitbpatel7 @gcfmd @RBPatelMD @FH_Verbrugge Time for rapid implementation of #CaReMe models ! @KidneyInCVD @AHAScience

0

10

Janani Rangaswami

@RangaswJ

3 years

Very exciting news indeed for the # cardiorenal community ! @KidneyInCVD @BhallaResearch @DrRajivsankar @AgarwalRajivMD @BakrisGeorge

Muthu Vaduganathan

@mvaduganathan

3 years

Exciting news for pts with #CKD & #T2D Finerenone (Kerendia®), nonsteroidal selective #MRA now @US_FDA approved to ↓ eGFR decline, ESKD, CVd, MI, & HF hosp based on #FIDELIODKD . Awaiting full data from positive #FIGARODKD & pooled #FIDELITY at #ESC2021

2

29

76

2

4

11

Janani Rangaswami

@RangaswJ

6 months

Many congrats to all the winners ! @KidneyInCVD @AHAScience @RajgopalRadhika @BhallaResearch @staruschenko

Kidney in Cardiovascular Disease

@KidneyInCVD

6 months

Congrats to the winners of the KCVD The Role of the Kidney in Cardiovascular Disease Educational Tools Contest Dr James Dr Ali and Dr Turk

3

9

29

1

4

11

Janani Rangaswami

@RangaswJ

1 year

Honored to be @SusanQuaggin ’s Twitter twin #heart -kidney 😊😊 @RangaswJ = @SusanQuaggin RangaswJ and SusanQuaggin are Twitter twins! #twitterTwin #toasteed

1

0

11

Janani Rangaswami

@RangaswJ

4 years

Very timely and relevant given disproportionate non -academic work burden faced by #WIM amplified by #COVID19 @DarilynMoyer @taminatorMD @LeiLeeMD #genderequity

Dr Natalie Matosin

@natalie_matosin

4 years

Ten simple rules for women principal investigators during a pandemic

4

19

42

0

4

11

Janani Rangaswami

@RangaswJ

7 months

This is incredible and many thanks for the support ! @KidneyFund @AHAScience @ChiadiNdumele @RajgopalRadhika @MariellJessup @MitchElkind

American Kidney Fund

@KidneyFund

7 months

This week, @HeartNews defined a new condition: cardiovascular-kidney-metabolic syndrome. Our statement on how we hope approaches for care & management will improve screening & health outcomes. LINK:

0

3

10

0

1

11

Janani Rangaswami

@RangaswJ

4 years

Practice changing times in the Rx of # DKD. Exciting prospects for the use of “ triple therapy” with RAASi/SGLT2i/finerenone as we learn more about their complementary mechanistic pathways ⁦ @AgarwalRajivMD ⁩ ⁦ @mvaduganathan ⁩ ⁦⁦

Novel Drug Slows Progression of Diabetic Kidney Disease

Finerenone, a selective, nonsteroidal mineralocorticoid receptor antagonist, significantly reduced both renal and cardiovascular events, with good tolerability, in the FIDELIO-DKD trial.

www.medscape.com

1

4

11

Janani Rangaswami

@RangaswJ

3 years

Adding my bit to #SockItToKidneyDisease with ⁦⁦⁦ @onepeloton ⁩ #850challenge on #WorldKidneyDay 😀⁦ @SusanQuaggin ⁩ ⁦ @NU_Nephrology ⁩ ⁦ @KidneyInCVD ⁩ ⁦ @DrRajivsankar ⁩ ⁦ @BhallaResearch ⁩ #cardiorenal

2

0

11

Janani Rangaswami

@RangaswJ

6 months

Join @ChiadiNdumele , @joshuajosephmd , #Lawrence Sperling and I in Learning Studio 1 now for a case based discussion of # CKM syndrome and the #AHA CKM Presidential Advisory😊 @KidneyInCVD @AHAMeetings @AHAScience #AHA23

1

4

10

Janani Rangaswami

@RangaswJ

1 year

Delighted to have superstar #cardiorenal mentee #Shay Vellanki matching at @ucla cardiology! Look forward to more exciting work in the #CaReMe space ftom this future cardiologist @GW_MFA @ChavonOnumah @annarubinmd @AHAScience @uclaCVfellows

Eric H Yang, MD

@datsunian

1 year

INTRODUCING...*🥁* Our @DOM_UCLA @uclaCVfellows Class of 2026! @kewatson @netta_doc @HayaseJustin @arafiqmd1 & I welcome you to @UCLAHealth , ☀️, a phenomenal training experience...and above all else, our awesome #bruinhearts family!!!

5

13

143

1

11

Janani Rangaswami

@RangaswJ

6 months

Look forward to this cutting edge session on cardio- kidney outcomes in clinical trials hosted by @KidneyInCVD @AHAMeetings !!

Brendon Neuen

@brendonneuen

6 months

Join me, @mvaduganathan , @KBreathettMD , Dr Ileana Pina, Dr Roy Mathew & @kershawpatel at 9:45AM on Saturday at #AHA23 for a deep dive into cardio-renal outcomes in clinical trials

0

9

28

0

3

11

Janani Rangaswami

@RangaswJ

4 years

Really nice summary by @Nephro_Sparks , @hswapnil and @asouth_neph on the escalating #FakeNews about #ACEI and #ARB in #COVID ー19 . Ensuring stability with chronic conditions is key in avoiding non COVID-19 admissions that will paralyze the health system.

Matthew Sparks, MD

@Nephro_Sparks

4 years

The Coronavirus Conundrum: ACE2 and Hypertension Edition on #NephJC Curated by @hswapnil @Nephro_Sparks with @asouth_neph DM to add/discuss #Covid_19

4

30

61

0

4

11